Business

The Indian Solution for Obamacare

The Indian Solution for Obamacare

While the United States was fighting its all-consuming political war over Obamacare in 2012, a quieter argument was gaining ground in health-policy circles: the most important lessons for fixing American healthcare might be coming from India.

The evidence was in places like Aravind Eye Care in Madurai, which performs hundreds of thousands of cataract surgeries a year at a cost per surgery that is a small fraction of the American price — with outcomes that match or exceed Western benchmarks. Or Narayana Hrudayalaya in Bangalore, where Devi Shetty's cardiac hospitals perform heart surgery at volumes and prices that made American hospital administrators stare: high volume, extreme standardization, and relentless process engineering driving unit costs down without visibly degrading quality.

The mechanism was what the management literature called frugal or reverse innovation — achieving comparable outcomes at radically lower cost through scale, specialization, and the elimination of everything that doesn't improve the result. Atul Gawande's 2012 New Yorker essay on the model brought it to an American audience just as the Affordable Care Act's cost-control provisions were being debated.

The American objection was always the same: that quality must suffer at those prices. But the data from the Indian institutions kept refusing to cooperate with that assumption. The surgeons were excellent, the protocols were rigorous, and the outcomes were published.

The deeper lesson was uncomfortable for both sides of the American debate. The left wanted universal coverage; the right wanted market discipline. India's low-cost hospitals suggested that the cost disease itself — the assumption that healthcare must get more expensive every year — was partly a design choice, not a law of nature. Systems designed around throughput and standardization delivered care at prices that systems designed around fee-for-service billing could not touch.

Obamacare's fate would be decided by courts and elections. But the Indian example reframed the question: what if the problem wasn't who pays for healthcare, but how much of it we were paying for unnecessarily?

This article is an original essay on the well-documented 2012-era frugal-innovation healthcare debate.

Aravind Eye Carefrugal innovationhealthcareNarayana HrudayalayaObamacare

Related Stories

Reebok's $25 Million Mistake
Business

Reebok's $25 Million Mistake

On September 28, 2011, Reebok agreed to pay $25 million to settle FTC charges that its EasyTone and RunTone toning shoes' fitness claims were deceptive.